Bausch Health Companies Inc.
US ˙ NYSE ˙ CA0717341071

SecurityBHC / Bausch Health Companies Inc.
InstitutionVan Eck Associates Corp
Latest Disclosed Ownership238,036 shares
Latest Disclosed Value $ 1,285
Van Eck Associates Corp reports 15.31% increase in ownership of BHC / Bausch Health Companies Inc.

On May 15, 2026 - Van Eck Associates Corp filed a 13F-HR form disclosing ownership of 238,036 shares of Bausch Health Companies Inc. (US:BHC) valued at $1,285,394 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 206,438 shares of Bausch Health Companies Inc.. This represents a change in shares of 15.31% during the quarter. The current value of the position is $1,178,278 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F Bausch Health Cos COM 071734107 238,036 31,598 15.31 1 0.00 0.0008
2026-02-13 2025-12-31 13F Bausch Health Cos COM 071734107 206,438 90,948 78.75 1 0.0012
2025-11-13 2025-09-30 13F Bausch Health Cos COM 071734107 115,490 -15,736 -11.99 1 0.0007
2025-08-14 2025-06-30 13F Bausch Health Cos COM 071734107 131,226 -335,926 -71.91 1 -100.00 0.0010
2025-05-15 2025-03-31 13F Bausch Health Cos COM 071734107 467,152 243,732 109.09 3 200.00 0.0039
2025-01-29 2024-12-31 13F Bausch Health Cos COM 071734107 223,420 -119,848 -34.91 2 -50.00 0.0023
2024-10-29 2024-09-30 13F Bausch Health Cos COM 071734107 343,268 40,797 13.49 3 0.00 0.0035
2024-07-31 2024-06-30 13F Bausch Health Cos COM 071734107 302,471 11,379 3.91 2 -33.33 0.0030
2024-04-30 2024-03-31 13F Bausch Health Cos COM 071734107 291,092 -94,392 -24.49 3 0.00 0.0047
2024-02-05 2023-12-31 13F Bausch Health Cos COM 071734107 385,484 -119,773 -23.71 3 -25.00 0.0056
2023-11-08 2023-09-30 13F Bausch Health Cos COM 071734107 505,257 -105,299 -17.25 4 0.00 0.0091
2023-08-03 2023-06-30 13F Bausch Health Cos COM 071734107 610,556 254,075 71.27 5 100.00 0.0107
2023-05-03 2023-03-31 13F Bausch Health Cos COM 071734107 356,481 -301,015 -45.78 3 -50.00 0.0066
2023-02-08 2022-12-31 13F Bausch Health Cos COM 071734107 657,496 97,700 17.45 4 -99.90 0.0107
2022-10-27 2022-09-30 13F Bausch Health Cos COM 071734107 559,796 -202,485 -26.56 3,857 -39.48 0.0115
2022-08-03 2022-06-30 13F Bausch Health Cos COM 071734107 762,281 317,964 71.56 6,373 -37.23 0.0169
2022-05-10 2022-03-31 13F Bausch Health Cos COM 071734107 444,317 19,551 4.60 10,153 -13.42 0.0210
2022-01-26 2021-12-31 13F Bausch Health Cos COM 071734107 424,766 82,819 24.22 11,727 23.14 0.0271
2021-11-03 2021-09-30 13F Bausch Health Cos COM 071734107 341,947 95,547 38.78 9,523 31.81 0.0239
2021-08-10 2021-06-30 13F Bausch Health Cos COM 071734107 246,400 -211,849 -46.23 7,225 -50.33 0.0171
2021-05-13 2021-03-31 13F Bausch Health Cos COM 071734107 458,249 94,057 25.83 14,545 92.01 0.0396
2021-02-09 2020-12-31 13F Bausch Health Cos COM 071734107 364,192 7,913 2.22 7,575 36.81 0.0221
2020-12-04 2020-09-30 13F/A-1 Bausch Health Cos COM 071734107 356,279 -31,440 -8.11 5,537 -21.92 0.0176
2020-11-12 2020-09-30 13F Bausch Health Cos COM 071734107 356,279 -31,440 5,537 17,166.6597
2020-08-14 2020-06-30 13F/A-1 Bausch Health Cos COM 071734107 387,719 45,889 13.42 7,091 33.84 0.0247
2020-08-10 2020-06-30 13F Bausch Health Cos COM 071734107 387,719 45,889 7,091 24,089.9095
2020-05-12 2020-03-31 13F Bausch Health Cos COM 071734107 341,830 60,917 21.69 5,298 -36.97 0.0269
2020-02-13 2019-12-31 13F Bausch Health Cos COM 071734107 280,913 48,214 20.72 8,405 65.32 0.0325
2019-11-08 2019-09-30 13F Bausch Health Cos COM 071734107 232,699 -125,116 -34.97 5,084 -43.66 0.0238
2019-08-07 2019-06-30 13F Bausch Health Cos COM 071734107 357,815 2,122 0.60 9,024 2.71 0.0435
2019-05-13 2019-03-31 13F Bausch Health Cos COM 071734107 355,693 -109,222 -23.49 8,786 2.32 0.0432
2019-02-12 2018-12-31 13F Bausch Health Cos COM 071734107 464,915 -50,565 -9.81 8,587 -35.10 0.0431
2018-11-13 2018-09-30 13F Bausch Health Cos COM 071734107 515,480 20,894 4.22 13,232 15.12 0.0645
2018-08-13 2018-06-30 13F Bausch Health Cos COM 071734107 494,586 494,586 11,494 0.0537
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.